Nature communications

phytotherapy research : ptr

PloS one

ACS omega

International journal of environmental research and public health

Chemistry & biodiversity

Acta psychologica

International journal for quality in health care : journal of the International Society for Quality in Health Care

BMJ

clinical therapeutics

Advances in therapy

expert opinion on therapeutic targets

lipids in health and disease

african health sciences

metabolism: clinical and experimental

pediatric nephrology (berlin, germany)

zhonghua nei ke za zhi

the annals of thoracic surgery

science (new york, ny)

proceedings symposium on computer architecture and high performance computing

zhonghua shi yan he lin chuang bing du xue za zhi = zhonghua shiyan he linchuang bingduxue zazhi = chinese journal of experimental and clinical virology

[1] Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty.

[2] Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport.

[3] Efficient irregular wavefront propagation algorithms on Intel Xeon Phi.

[4] Ultrastructural and functional fate of recycled vesicles in hippocampal synapses.

[5] 'Are We Not Human?' Stories of Stigma, Disability and HIV from Lusaka, Zambia and Their Implications for Access to Health Services.

[6] Working memory capacity and dual-task interference in picture naming.

[7] [Comparative study on the effect of highly active antiretroviral therapy (HAART) in patients with HIV infection acquired by blood transfusion and paid plasma donation].

[8] Down-regulated of SREBP-1 in circulating leukocyte is a risk factor for atherosclerosis: a case control study.

[9] The neural basis of combinatory syntax and semantics.

[10] Residual SYNTAX Score after Advanced Hybrid Robotic Totally Endoscopic Coronary Revascularization.

[11] Management of dyslipidemia in pediatric renal transplant recipients.

[12] [China cholesterol education program (CCEP) expert advice for the management of dyslipidaemias to reduce cardiovascular risk (2019)].

[13] Effects of gender, age and treatment duration on lipid profile and renal function indices in diabetic patients attending a teaching hospital in South-Western Nigeria.

[14] Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care

[15] rutaecarpine exhibits anti-diabetic potential in high fat diet–multiple low dose streptozotocin induced type 2 diabetic mice and in vitro by modulating hepatic glucose homeostasis

[16] the relationship between dyslipidemia and disease activity in iranian population with systemic lupus erythematosus

[17] influência do modo de preparo de alimentos na prevenção da aterosclerose the influence of food preparation methods on atherosclerosis prevention

[18] aerobic exercise training selectively changes oxysterol levels and metabolism reducing cholesterol accumulation in the aorta of dyslipidemic mice

[19] drug lag for cardiovascular drug approvals in india compared with the us and eu approvals

[20] metabolic syndrome among type-2 diabetic patients in benghazi-libya: a pilot study

[21] assessment of lipid lowering effect of nepeta hindostana herb extract in experimentally induced dyslipidemia

[22] primary prevention of cardiovascular disease

[23] atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in southeast nigeria

[24] lipitension : interplay between dyslipidemia and hypertension

[25] the use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia

[26] fatores de risco para aterosclerose em crianças e adolescentes com história familiar de doença arterial coronariana prematura risk factors for atherosclerosis in children and adolescents with family history of premature coronary artery disease

[27] association between eight functional polymorphisms and haplotypes in the cholesterol ester transfer protein (cetp) gene and dyslipidemia in national minority adults in the far west region of china

[28] association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents

[29] Dissecting the role of insulin resistance in the metabolic syndrome

[30] Viscosol Treatment Ameliorates Insulin-Mediated Regulation of Dyslipidemia, Hepatic Steatosis, and Lipid Metabolism by Targeting PTP1B in Type-2 Diabetic Mice Model.

[31] Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.

[32] Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study

[33] Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study

[34] Genes associated with free fatty acid levels and dyslipidemia in type 2 diabetes patients

[35] DYSLIPIDEMIA AS A FACTOR FOR PROGRESSION OF RENAL OSTEODYSTROPHY AND CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON PERITONEAL DIALYSIS

[36] Anti diabetic and anti dyslipidemia activities of Cleome gynandra in alloxan induced diabetic rats

[37] Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport.

[38] Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation.

[39] Whole barley prevents obesity and dyslipidemia without the involvement of the gut microbiota in germ free C57BL/6J obese mice.

[40] Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States: GOULD Registry Methods and Baseline Data

[41] Analysis of a clinical case: Medical nutrition therapy in a newly diagnosed diabetes with obesity, hypertension and dyslipidemia. 1st part: The nutritional assessment

[42] Management of dyslipidemia in pediatric renal transplant recipients.

[43] Cacao beans extract (Theobroma cacao L.) improve lipid profile but had no effect on blood nox concentration in dyslipidemia white male rat (Rattus norvegicus)

[44] Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015.

[45] A STUDY OF METABOLIC PARAMETERS IN NON DIABETIC PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE - IMPORTANCE OF DYSLIPIDEMIA.

[46] Association of fetuin-a with dyslipidemia and insulin resistance in type-II diabetics of Pakistani population

[47] Effect of insulin verses metformin on hyper-glycemia and dyslipidemia in type-ii diabetic patients

[48] Autophagy protects peripheral blood mononuclear cells against inflammation, oxidative and nitrosative stress in diabetic dyslipidemia

[49] Diabetic dyslipidemia with eruptive xanthoma

[50] The efficacy of Nigella Sativa L extracts to reduce cardiovascular disease risk in diabetic dyslipidemia

[51] An update on pharmacotherapies in diabetic dyslipidemia

[52] New dual peroxisome proliferator activated receptor agonist - Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: Integrated analysis of the real world evidence

[53] Association of variants rs7903146 and rs290487 of TCF7L2 gene with diabetic nephropathy and co-morbidities (hypertension and dyslipidemia) in type 2 diabetes mellitus

[54] Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats

[55] Prevalence of dyslipidemia associated with complications in diabetic patients: A nationwide study in Thailand

[56] Relation of homocysteine with malondialdehyde and dyslipidemia in type 2 diabetic patients with coronary artery diseases

[57] Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review

[58] Future perspectives of the pharmacological management of diabetic dyslipidemia

[59] Potential therapeutic effect of Moroccan propolis in hyperglycemia, dyslipidemia, and hepatorenal dysfunction in diabetic rats

[60] Impact of glycaemia, dyslipidemia and anxiety level on oxidative stress in prediabetic and diabetic patients

[61] A randomized controlled trial of a herbal compound for improving metabolic parameters in diabetic patients with uncontrolled dyslipidemia

[62] The prevalence and risk factors associated with dyslipidemia in type 2 diabetic patients in the autonomous Region of Cantabria

[63] The treatment of diabetic dyslipidemia based on pathophysiological mechanisms

[64] Evaluation of the circulating betatrophin concentration and its possible correlations among diabetic patients with dyslipidemia

[65] The APoE^∗3-Leiden heterozygous glucokinase knockout mouse as novel translational disease model for type 2 diabetes, dyslipidemia, and diabetic atherosclerosis

[66] A contemporary overview of PPARα/γ dual agonists for the management of diabetic dyslipidemia

[67] Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: A place far from heaven

[68] Pathogenesis and significance of diabetic dyslipidemia

[69] Prevalence of dyslipidemia among the diabetic patients in southern Bangladesh: A cross-sectional study

[70] Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID)

[71] Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea.

[72] Rice bran attenuated obesity via alleviating dyslipidemia, browning of white adipocytes and modulating gut microbiota in high-fat diet-induced obese mice.

[73] Maternal hypercholesterolemia programs dyslipidemia in adult male mouse progeny.

[74] Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India

[75] dyslipidemia and breast cancer

[76] comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: a randomized, open-label, multicenter clinical trial in indian population

[77] low hdl, the most common type of dyslipidemia in birjand studies: it is necessary to study: letter to editor

[78] extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters

[79] the relationship between dyslipidemia and disease activity in iranian population with systemic lupus erythematosus

[80] correlation between traditional chinese medicine constitution and dyslipidemia: a systematic review and meta-analysis

[81] simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial

[82] nutraceuticals and bioactive components from fish for dyslipidemia and cardiovascular risk reduction

[83] assessment of lipid lowering effect of nepeta hindostana herb extract in experimentally induced dyslipidemia

[84] associations of fatty liver disease with hypertension, diabetes, and dyslipidemia: comparison between alcoholic and nonalcoholic steatohepatitis

[85] dyslipidemia in women: etiology and management

[86] lipitension : interplay between dyslipidemia and hypertension

[87] risco e assistência à dislipidemia no climatério risk factors and assistance to dyslipidemia in climacteric women

[88] treatment of patients with severe dyslipidemia in real clinical practice

[89] role of complementary and alternative medicine in controlling dyslipidemia

[90] the use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia

[91] management of dyslipidemia in renal disease and transplantation

[92] dislipidemia en el sÍndrome de preemclapsia / dyslipidemia in preeclampsia syndrome

[93] drugs involved in dyslipidemia and obesity treatment: focus on adipose tissue

[94] association between eight functional polymorphisms and haplotypes in the cholesterol ester transfer protein (cetp) gene and dyslipidemia in national minority adults in the far west region of china

[95] screening for dyslipidemia and expedience of statin therapy for the citizens of transcarpathia valley regions with overweight and obesity

[96] fenugreek seed extract inhibit fat accumulation and ameliorates dyslipidemia in high fat diet-induced obese rats

[97] the correlation of dyslipidemia with the extent of coronary artery disease in the multiethnic study of atherosclerosis

[98] jtt-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats

[99] association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents

[100] simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence

[101] Drugs for Dyslipidemias